{
  "cik": 1826457,
  "cik_padded": "0001826457",
  "entityName": "Monte Rosa Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-109360",
      "filed": "2026-03-17",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "dividends_paid": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 4700000.0,
        "cash": 129883000.0,
        "dividends_paid": 0.0,
        "free_cash_flow": -27498000.0,
        "net_income": -38626000.0,
        "operating_cash_flow": -22798000.0,
        "operating_income": -54208000.0,
        "revenue": 123672000.0,
        "stockholders_equity": 233056000.0,
        "total_assets": 448659000.0,
        "total_liabilities": 215603000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.9251124193326926,
        "net_margin": -0.3123261530500032,
        "operating_margin": -0.4383207193220777,
        "revenue_growth_yoy": 0.6353971066620825,
        "roa_avg2y": -0.08705519889203293,
        "roa_period_end": -0.08609211004348515,
        "roe_avg2y": -0.16941525289917367,
        "roe_period_end": -0.1657369902512701
      }
    },
    {
      "accn": "0001193125-26-109360",
      "filed": "2026-03-17",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "dividends_paid": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3988000.0,
        "cash": 224254000.0,
        "dividends_paid": 0.0,
        "free_cash_flow": 38008000.0,
        "net_income": -72700000.0,
        "operating_cash_flow": 41996000.0,
        "operating_income": -81112000.0,
        "revenue": 75622000.0,
        "stockholders_equity": 222936000.0,
        "total_assets": 438732000.0,
        "total_liabilities": 215796000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.9679728711379051,
        "net_margin": -0.9613604506625056,
        "operating_margin": -1.0725979212398509,
        "roa_avg2y": -0.19582834446933078,
        "roa_period_end": -0.16570480384380443,
        "roe_avg2y": -0.36152426986518676,
        "roe_period_end": -0.3261025585818351
      }
    },
    {
      "accn": "0001193125-26-109360",
      "filed": "2026-03-17",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "dividends_paid": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 19041000.0,
        "cash": 128101000.0,
        "dividends_paid": 0.0,
        "free_cash_flow": -62843000.0,
        "net_income": -135352000.0,
        "operating_cash_flow": -43802000.0,
        "operating_income": -143311000.0,
        "stockholders_equity": 179250000.0,
        "total_assets": 303755000.0,
        "total_liabilities": 124505000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.6945885634588563,
        "roa_avg2y": -0.41895305071315375,
        "roa_period_end": -0.4455959572681931,
        "roe_avg2y": -0.6006794433978383,
        "roe_period_end": -0.7551018131101813
      }
    },
    {
      "accn": "0000950170-25-042344",
      "filed": "2025-03-20",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "dividends_paid": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 12911000.0,
        "cash": 54912000.0,
        "dividends_paid": 0.0,
        "free_cash_flow": -105377000.0,
        "net_income": -108501000.0,
        "operating_cash_flow": -92466000.0,
        "operating_income": -112384000.0,
        "stockholders_equity": 271413000.0,
        "total_assets": 342389000.0,
        "total_liabilities": 70976000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2615055284750546,
        "roa_avg2y": -0.30618948580394456,
        "roa_period_end": -0.3168939422703416,
        "roe_avg2y": -0.35060944083964535,
        "roe_period_end": -0.3997634601142907
      }
    },
    {
      "accn": "0000950170-24-031150",
      "filed": "2024-03-14",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "dividends_paid": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 9732000.0,
        "cash": 346071000.0,
        "dividends_paid": 0.0,
        "free_cash_flow": -69095000.0,
        "net_income": -73958000.0,
        "operating_cash_flow": -59363000.0,
        "operating_income": -72882000.0,
        "stockholders_equity": 347515000.0,
        "total_assets": 366329000.0,
        "total_liabilities": 18814000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.054138670273225616,
        "roa_avg2y": -0.3558179198329593,
        "roa_period_end": -0.20188955829322822,
        "roe_avg2y": -0.4950550057398749,
        "roe_period_end": -0.2128195905212725
      }
    },
    {
      "accn": "0000950170-23-008440",
      "filed": "2023-03-16",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3389000.0,
        "cash": 41699000.0,
        "free_cash_flow": -26442000.0,
        "net_income": -35879000.0,
        "operating_cash_flow": -23053000.0,
        "operating_income": -28010000.0,
        "stockholders_equity": -48728000.0,
        "total_assets": 49378000.0,
        "total_liabilities": 30342000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.7266191421280732
      }
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-109360",
    "filed": "2026-03-17",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001826457.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001826457.json"
  },
  "ticker": "GLUE"
}